Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
出版年份 2018 全文链接
标题
Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-05-31
DOI
10.1038/s41388-018-0340-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- α-Actinin-4 confers radioresistance coupled invasiveness in breast cancer cells through AKT pathway
- (2018) Sejal Desai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of STAT3 in leading the crosstalk between human cancers and the immune system
- (2018) Yu Wang et al. CANCER LETTERS
- Niclosamide: Beyond an antihelminthic drug
- (2018) Wei Chen et al. CELLULAR SIGNALLING
- Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway
- (2018) Yingying Jin et al. EXPERIMENTAL CELL RESEARCH
- Alkynyl gold(I) complex triggers necroptosis via ROS generation in colorectal carcinoma cells
- (2017) Inés Mármol et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
- (2017) B Peter et al. LEUKEMIA
- Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152
- (2017) Yu Wang et al. MOLECULAR CANCER THERAPEUTICS
- Breast Cancer
- (2017) Robert W. Carlson et al. Journal of the National Comprehensive Cancer Network
- Gene Expression Profiling in Breast Cancer
- (2017) Kiran Turaga et al. Cancer Control
- 3,3′-diindolylmethane mitigates total body irradiation-induced hematopoietic injury in mice
- (2016) Lu Lu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo
- (2016) Tae Jin Han et al. JOURNAL OF NEURO-ONCOLOGY
- Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
- (2016) Rebecca C. Arend et al. Oncotarget
- Abstract P6-12-04: Targeting STAT3 with novel small molecule inhibitors to sensitize breast cancer cells to radiation therapy
- (2015) Lili Wang et al. CANCER RESEARCH
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair
- (2015) Hai Liu et al. OncoTargets and Therapy
- Effect of Niclosamide on Basal-like Breast Cancers
- (2014) A. I. Londono-Joshi et al. MOLECULAR CANCER THERAPEUTICS
- AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells
- (2014) Tsutomu Shimura et al. RADIOTHERAPY AND ONCOLOGY
- Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
- (2013) S. You et al. MOLECULAR CANCER THERAPEUTICS
- DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism
- (2013) S. Fan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treating Breast Cancer in the 21st Century: Emerging Biological Therapies
- (2013) Gabriel Tinoco et al. Journal of Cancer
- Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells
- (2012) Xiaoying Liu et al. BIOCHEMICAL PHARMACOLOGY
- Disrupting the mTOR Signaling Network as a Potential Strategy for the Enhancement of Cancer Radiotherapy
- (2012) Francis J. Dumont et al. CURRENT CANCER DRUG TARGETS
- mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring anEGFRactivating mutation by inducing autophagy
- (2012) Eun Ju Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
- (2012) Jing-Xuan Pan et al. Chinese Journal of Cancer
- High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
- (2011) W. Warsch et al. BLOOD
- Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer
- (2011) Leonel F. Hernandez-Aya et al. JOURNAL OF CLINICAL ONCOLOGY
- Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
- (2011) Xiang-Ping Yang et al. NATURE IMMUNOLOGY
- Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF- B Pathway and Generation of Reactive Oxygen Species
- (2010) Y. Jin et al. CANCER RESEARCH
- Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3β-mediated cyclin D1 overexpression
- (2010) T Shimura et al. ONCOGENE
- Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
- (2010) Xiaomei Ren et al. ACS Medicinal Chemistry Letters
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
- Reciprocal Effects of STAT5 and STAT3 in Breast Cancer
- (2009) S. R. Walker et al. MOLECULAR CANCER RESEARCH
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started